Brief: Prostatype Genomics H2 EBITDA Loss Widens To SEK 17.8 Mln
15/02/2024 07:15
Feb 15 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* H2 NET SALES AMOUNTED TO 908 TSEK (414)
* H2 EBITDA -17,797 TSEK (-14,849)
Source text for Eikon: ID:nWkr7ZbtxN
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants